Dual RNA-seq unveils noncoding RNA functions in host–pathogen interactions
A. J. Westermann, K. U. Förstner, F. Amman.,L.Barquist, Y.Chao, L.N. Schulte,L.Müller, R. Reinhardt,P. F. Stadler & J. Vogel. Nature (2016) doi:10.1038/nature16547
In close cooperation with New England Biolabs, Inc. (NEB), VERTIS is now able to make the new Cappable-seq method available to its customers. The method was developed by Laurence Ettwiller and Ira Schildkraut from NEB (Ettwiller, L. et al. 2016. BMC Genomics. 17, 1 (2016), 199).
It represents the current most sensitive and robust method for the precise identification of bacterial transcription start sites (TSSs).
By Regular Mail |
![]() | |
Vertis Biotechnologie AG
Lise-Meitner-Straße 30
85354 Freising Germany | ||
|
| |
By Phone | ||
Phone: |
+49 (0)8161 18516 11 | |
Fax: |
+49 (0)8161 18516 12 | |
|
| |
By Email | ||
email: |
Also, you can complete our on-line Service Request Form.